Publication | Closed Access
<i>RUNX3</i> methylation as a predictor for disease progression in patients with non‐muscle‐invasive bladder cancer
32
Citations
20
References
2011
Year
RUNX3 methylation status predicted the risk of NMIBC progression independently of tumor stage. In conjunction with tumor grade, RUNX3 methylation status in patients with NMIBC strongly predicts disease progression.
| Year | Citations | |
|---|---|---|
Page 1
Page 1